Flora Growth Corp. Common Stock logo

FLGC Q3 2025 Earnings Results — Flora Growth Corp. Common Stock

XNAS · Healthcare · Drug Manufacturers - Specialty & Generic

Updated

Price $8.70
Market Cap $6.6M
P/E —
52W Range $8.11 – $81.90

When is FLGC's next earnings date?

Flora Growth Corp. Common Stock (FLGC) has not announced its next earnings date yet. Its most recent earnings report was on Wednesday, November 5, 2025.

How did FLGC do in its last earnings report?

In its most recent report on Nov 5, 2025 (Q3 2025), Flora Growth Corp. Common Stock posted EPS of -$4.93 versus the -$2.07 estimate, a miss of 138.2%. Revenue was $9.7M against a $12.1M estimate. The stock's 1-day post-earnings move was -15.2%.

How much does FLGC stock move after earnings?

FLGC beat EPS estimates in 1 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 6.7% (up or down) in the day after earnings.

About Flora Growth Corp. Common Stock

Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2025-11-05Q3 2025-2.07-4.93-138.16%$9.7M❌ Miss-15.21%-11.47%+6.84%
2025-08-01Q2 2025-0.06-0.11-83.33%$14.8M❌ Miss+7.94%-5.66%+14.18%
2025-03-24Q4 2024-0.11-0.45-309.09%$13.3M❌ Miss+2.58%-7.88%-16.28%
2024-11-13Q3 2024-0.08-0.25-212.50%$12.5M❌ Miss+15.93%+7.96%+15.04%
2024-08-12Q2 2024-0.04-0.22-450.00%$15.7M❌ Miss+0.00%+0.06%+1.08%
2024-05-14Q1 2024-0.22-0.38-72.73%$18.0M❌ Miss+3.91%-6.25%-11.72%
2024-03-28Q4 2023-0.07-0.50-614.29%$18.0M❌ Miss-1.30%+3.03%-44.59%
2023-11-08Q3 2023-0.200.08+140.00%$17.3M✅ Beat-6.99%+6.56%+36.90%

Showing last 8 quarters.

Revenue by segment & region

By region

Q2 FY26 · $13.7M total

SegmentShareRevenueYoY
GERMANY92.5%$12.6M+27.9%
UNITED STATES7.5%$1.0M-76.8%

Source: company filings via FMP. YoY compares the same fiscal period a year earlier.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .